Cargando…
AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway
Current clinical challenges of prostate cancer management are to restrict tumor growth and prohibit metastasis. AICAR (5-aminoimidazole-4-carbox-amide-1-β-d-ribofuranoside), an AMP-activated protein kinase (AMPK) agonist, has demonstrated antitumor activities for several types of cancers. However, t...
Autores principales: | Su, Chia-Cheng, Hsieh, Kun-Lin, Liu, Po-Len, Yeh, Hsin-Chih, Huang, Shu-Pin, Fang, Shih-Hua, Cheng, Wei-Chung, Huang, Kuan-Hua, Chiu, Fang-Yen, Lin, I-Ling, Huang, Ming-Yii, Li, Chia-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480054/ https://www.ncbi.nlm.nih.gov/pubmed/30987073 http://dx.doi.org/10.3390/ijms20071647 |
Ejemplares similares
-
The AMPK Agonist AICAR Inhibits TGF-β1 Induced Activation of Kidney Myofibroblasts
por: Chen, Kuan-Hsing, et al.
Publicado: (2014) -
Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
por: Su, Chia-Cheng, et al.
Publicado: (2021) -
AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy
por: Rae, Colin, et al.
Publicado: (2019) -
Hesperetin Induces Autophagy and Delayed Apoptosis by Modulating the AMPK/Akt/mTOR Pathway in Human Leukemia Cells In Vitro
por: Lin, Ching-Yeh, et al.
Publicado: (2023) -
Prior Treatment with AICAR Causes the Selective Phosphorylation of mTOR Substrates in C2C12 Cells
por: Dedert, Cass J., et al.
Publicado: (2023)